中文

Journal Publications

[1]CJ Cai, YH Liu, S Zeng, H Shen *, Y Han *. The efficacy of COVID-19 vaccines against the B.1.617.2 (delta) variant. Mol Therapy. 2021 Oct 1; S1525-0016 (21)00479-2
[2]CJ Cai, YH Peng, E Shen, QQ Huang, YH Chen, P Liu, C Guo, ZY Feng, L Gao, XY Zhang, Y Gao, Liu YH, Y Han *, S Zeng *, H Shen *. A comprehensive analysis of the efficacy and safety of COVID-19 vaccines. Mol Therapy. 2021 Aug 6; S1525-0016(21)00395-6.
[3]CJ Cai, J Long, QQ Huang, Y Han, YH Peng, C Guo, SS Liu, YH Chen, Edward Shen, KX Long, XW Wang, J Yu, H Shen *, S Zeng *. M6A “Writer” Gene METTL14: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal Cancer. Frontiers in Oncology. 2021 Jun 17; 11: 615296.
[4]YT Liu, Y Han, S Zeng, H Shen *. In respond to commensal bacteria: γδT cells play a pleiotropic role in tumor immunity. Cell Biosci. 2021 Mar 2; 11(1): 48.
[5]W Pang, YS Li, WH Guo, H Shen *. Cyclin E: a potential treatment target to reverse cancer chemoresistance by regulating the cell cycle. Am J Transl Res. 2020 Sep 15; 12(9): 5170-5187.
[6]CJ Cai, DY Tang, Y Han, Edward Shen, O Abdihamid Ahmed, C Guo, H Shen *, S Zeng *. A comprehensive analysis of the fatal toxic effects associated with CD19 CAR-T cell therapy. Aging - US. 2020 Sep 24; 12(18):18741-18753.
[7]WT Wu, YH Liu, S Zeng *, Y Han *, H Shen *. Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes. J Hematol Oncol. 2021 Oct 7; 14(1): 160.
[8]JY Ma, LJ Huang, D Hu, S Zeng *, Y Han *, H Shen *. The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor? J Exp Clin Cancer Res. 2021 Oct 16; 40(1): 327.
[9]CJ C, XY Zhang, Y Liu, E Shen, ZY Feng, C Guo, Y Han, YH Ouyang *, H Shen *. Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality. Gut Pathogens. 2021 Dec 4; 13(1): 70.
[10]Y Han, YH Peng, SS Liu, XW Wang, CJ Cai, C Guo, YH Chen, L Gao, QQ Huang, M He, Edward Shen, J Long, J Yu *, H Shen *, S Zeng *. tRF3008A suppresses the metastasis and progression of colorectal cancer by destabilizing FOXK1 in an AGO-dependent manner. J Exp Clin Cancer Res. 2022 Jan 22; 41(1): 32.
[11]CJ Cai, YH Peng, Edward Shen, RJ Wan, L Gao, Y Gao, YL Zhou, QQ Huang, YH Chen, P Liu, C Guo, ZY Feng, XY Zhang, YH Liu, H Shen *, S Zeng *, Y Han *. Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model. EBioMedicine. 2022 Feb 7; 76: 103866.
[12]YJ Fu, SS Liu, RM Rodrigues, Y Han, C Guo, ZW Zhu, Y He, B Mackowiak, DC Feng, B Gao *, S Zeng *, H Shen *. Activation of vasoactive intestinal polypeptide type-I receptor suppresses hepatocellular carcinoma progression by regulating arginine and pyrimidine metabolism. Intl J Biol Sci. 2022 Jul 4; 18(11): 4341-4356.
[13]Liu P, Zhu Z, Ma J, Wei L, Han Y, Shen E, Tan X, Chen Y, Cai C, Guo C, Peng Y, Gao Y, Liu Y, Huang Q, Gao L, Li Y, Jiang Z, Wu W, Liu Y, Zeng S, Li W *, Feng Z *，Shen H *. Prognostic stratification based on m5C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma. Front Immunol. 2022 Sep 9; 13: 951529.
[14]QQ Huang #, Y Han #, Edward Shen, ZY Feng,YH Peng, L Gao, Y Gao, YT Liu, W Li, P Liu, C Guo, S Zeng, CJ Cai *, H Shen *. MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma. iScience. 2022 Sep 10; 26(1):105095
[15]YT Liu, YH Ouyang, ZY Feng, ZH Jiang, JY Ma, X Zhou, CJ Cai, Y Han, S Zeng, SS Liu *, H Shen *. RASGRP2 is a potential immune-related biomarker and regulates mitochondrial-dependent apoptosis in lung adenocarcinoma. Front Immunol. 2023 Feb 3; 14: 1100231.
[16]YT Liu, ZH Jiang, X Zhou, Y Li, P Liu, YH Chen, J Tan, CJ Cai, Y Han, S Zeng, H Shen*, ZY Feng. A Multi-Omics Analysis of NASH-Related Prognostic Biomarkers Associated with Drug Sensitivity and Immune Infiltration in Hepatocellular Carcinoma. J Clin Med. 2023 Feb 6; 12(4): 1286.
[17]WH Guo, YS Li, W Pang, H Shen *. Exosomes：A potential therapeutic tool targeting the communication between tumor cells and macrophages. Mol Therapy. 2020 Jun 11; S1525-0016(20)30293-8.
[18]Y Han, YH Peng, YJ Fu, CJ Cai, C Guo, SS Liu, YY Li, YH Chen, Edward Shen , KX Long, XW Wang, J Yu, * , H Shen *, S Zeng *. MLH1 deficiency induces cetuximab resistance in colon cancer via Her-2/PI3K/AKT signaling. Advanced Science. Accepted.
[19]H Zhang, YL Zhou, BQ Cui, ZX Liu *, H Shen *. Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma. Biomedicine & Pharmacotherapy, 2020 June, 126: 110086.
[20]YJ Fu, SS Liu, S Zeng，H Shen *. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 2019 Aug 9; 38(1): 396.

total103 1/6

firstpreviousnext last Page

申竑

Zip Code:
Fax:
Postal Address:
Office Phone:
Email:

Central South University All rights reserved 湘ICP备05005659号-1

Click:

The Last Update Time:..